Search Results - "Burke, S E"

Refine Results
  1. 1
  2. 2

    Controlling the physicochemical properties of weak polyelectrolyte multilayer films through acid/base equilibria by Burke, S. E., Barrett, C. J.

    Published in Pure and applied chemistry (01-01-2004)
    “…Multilayer thin films prepared from weak polyelectrolytes can exhibit a rich suite of anomalous physicochemical properties. One of the major factors that…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Neointimal Formation After Balloon-Induced Vascular Injury in Yucatan Minipigs is Reduced by Oral Rapamycin by Burke, Sandra E, Lubbers, Nathan L, Chen, Yung-Wu, Hsieh, Gin C, Mollison, Karl W, Luly, Jay R, Wegner, Craig D

    Published in Journal of cardiovascular pharmacology (01-06-1999)
    “…Rapamycin, a macrolide antibiotic known to prevent allograft rejection, is a potent inhibitor of cell proliferation. Therefore we studied the effects of orally…”
    Get full text
    Journal Article
  5. 5

    Thermodynamic and aggregation properties of sodium dodecyl sulfate in aqueous binary mixtures of isomeric butanediols by BURKE, S. E, ANDRECYK, S. L, PALEPU, R

    Published in Colloid and polymer science (01-02-2001)
    “…The effect of aqueous binary mixtures of isomeric butanediols on the micellization of sodium dodecyl sulfate has been investigated. Conductivity and…”
    Get full text
    Journal Article
  6. 6

    DISTRIBUTED SENSOR/ACTUATOR DESIGN FOR PLATES: SPATIAL SHAPE AND SHADING AS DESIGN PARAMETERS by Sullivan, J.M., Hubbard, Jr, J.E., Burke, S.E.

    Published in Journal of sound and vibration (12-06-1997)
    “…This paper will discuss two-dimensional distributed transducer shape and shading and their implications for the active control of plates. Two-dimensional…”
    Get full text
    Journal Article
  7. 7

    Factors influencing medical student self‐competence to provide weight management services by Doshi, R. S., Gudzune, K. A., Dyrbye, L. N., Dovidio, J. F., Burke, S. E., White, R. O., Perry, S., Yeazel, M., van Ryn, M., Phelan, S. M.

    Published in Clinical obesity (01-02-2019)
    “…Summary This study aimed to identify factors associated with high obesity care self‐competence among US medical students. The authors performed a…”
    Get full text
    Journal Article
  8. 8

    Retention of conditioning agent hyaluronan on hydrogel contact lenses by Scheuer, C.A, Fridman, K.M, Barniak, V.L, Burke, S.E, Venkatesh, S

    Published in Contact lens & anterior eye (01-12-2010)
    “…Abstract Hyaluronan, a member of the glycosaminoglycan family of biological polysaccharides, is a high-molecular-weight disaccharide polymer found throughout…”
    Get full text
    Journal Article
  9. 9

    Profile of recombinant pro-urokinase given by intraarterial versus intravenous routes of administration in a canine thrombosis model by Burke, S E, Lubbers, N L, Nelson, R A, Wegner, C D, Cox, B F

    Published in Thrombosis and haemostasis (01-02-1999)
    “…Catheter-directed thrombolysis has gained increasing acceptance for the treatment of patients who present with vascular occlusion; however, intravenous…”
    Get more information
    Journal Article
  10. 10

    Evidence for Vasoconstriction Mediated by the Endothelin-B Receptor in Domestic Swine by Burke, Sandra E, Nelson, Richard A, Lubbers, Nathan L, Ford, TaLesha T, Fu, Kai I, Padley, Robert J, Wegner, Craig D, Cox, Bryan F

    Published in Journal of cardiovascular pharmacology (01-06-2000)
    “…Endothelin-1 (ET-1), a potent vasoactive and mitogenic peptide, has been implicated in a number of cardiovascular diseases, including congestive heart failure,…”
    Get full text
    Journal Article
  11. 11

    Recombinant pro-urokinase requires heparin for optimal clot lysis and restoration of blood flow in a canine femoral artery thrombosis model by Burke, S E, Lubbers, N L, Nelson, R A, Henkin, J

    Published in Thrombosis and haemostasis (01-04-1993)
    “…Heparin is often used as an adjunct to thrombolytic therapy in order to prevent reocclusion of the patent vessels in patients with thrombotic disease…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Endothelin-Receptor Antagonist FR 139317 Reduces Infarct Size in a Rabbit Model When Given Before, But Not After, Coronary Artery Occlusion by Burke, Sandra E, Nelson, Richard A

    Published in Journal of cardiovascular pharmacology (01-01-1997)
    “…SUMMARYEndothelins are potent vasoactive peptides that exist as isoforms having different affinities for two main receptor subtypes, ETA and ETB. Based on…”
    Get full text
    Journal Article
  14. 14

    Synthesis and biological activity of 4-(diphenylmethyl)-.alpha.-[(4-quinolinyloxy)methyl]-1-piperazineethanol and related compounds by Sircar, Ila, Haleen, Steve J, Burke, Sandra E, Barth, Hubert

    Published in Journal of medicinal chemistry (01-11-1992)
    “…A series of 4-(diphenylmethyl)-alpha-[(4-quinolinyloxy)methyl]-1-pipe razineethanol and closely related compounds was synthesized and evaluated for cardiac and…”
    Get full text
    Journal Article
  15. 15

    Distributed transducer vibration control of thin plates by BURKE, S. E, HUBBARD, J. E

    “…This paper presents an energy-based analysis of the application of distributed, biaxial piezoelectric transducers for the vibration measurement and control of…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Comparison of dose regimens for the administration of recombinant pro-urokinase in a canine thrombosis model by Burke, S E, Lubbers, N L, Nelson, R A, Henkin, J

    Published in Thrombosis and haemostasis (01-05-1997)
    “…Pro-urokinase represents an important addition to the array of thrombolytic drugs currently available for clinical use because of its high clot specificity but…”
    Get more information
    Journal Article
  18. 18

    Differential effects of lys- and mini-plasminogen on clot lysis induced by recombinant urokinase and recombinant pro-urokinase in a canine thrombosis model by BURKE, S. E, DAVIDSON, D. J, LUBBERS, N. L, REININGER, I. M, HENKIN, J

    Published in Thrombosis research (15-09-1996)
    “…These studies were conducted to examine the lytic efficacy of recombinant urokinase (r-UK) and pro-urokinase (r-proUK) in the presence and absence of truncated…”
    Get full text
    Journal Article
  19. 19

    Reduction of canine myocardial infarct size by CI-959, an inhibitor of inflammatory cell activation by Burke, S E, Wright, C D, Potoczak, R E, Boucher, D M, Dodd, G D, Taylor, Jr, D G, Kaplan, H R

    Published in Journal of cardiovascular pharmacology (01-10-1992)
    “…CI-959, a cell-activation inhibitor that prevents the formation of oxygen-derived free radicals by inflammatory cells, was studied to determine its effects on…”
    Get more information
    Journal Article
  20. 20

    Responsiveness of platelets and coronary arteries from different species to synthetic thromboxane and prostaglandin endoperoxide analogues by Burke, Sandra E., Lefer, Allan M., Nicolaou, Kyriacos C., Smith, Gordon M., Smith, J. Bryan

    Published in British journal of pharmacology (01-02-1983)
    “…1 Platelet‐rich plasma (PRP) from humans, cats, dogs (after addition of 10 μm adrenaline), rabbits and guinea‐pigs aggregated in response to sodium…”
    Get full text
    Journal Article